Blog
RSS FeedPosted by Michael Wonder on 22 Jul 2021
NHS England unveils new Innovative Medicine Fund
21 July 2021 - NHS England has unveiled its new Innovative Medicines Fund, to ensure patients have early access to ...
Posted by Michael Wonder on 04 Jul 2021
ICER to test principle of fair access to fairly priced pharmaceuticals
2 July 2021 - The controversial approval last month by the FDA of Aduhelm (aducanumab) for patients with early-stage Alzheimer’s disease ...
Posted by Michael Wonder on 24 Jun 2021
National Medicines Policy review to begin in August 2021
24 June 2021 - The review of the National Medicines Policy will begin in August 2021. ...
Posted by Michael Wonder on 21 Jun 2021
Health equity and Medicaid transformation — operationalising President Biden’s agenda
19 June 2021 - President Biden has made reforms intended to “protect and strengthen Medicaid” a centrepiece of his health policy ...
Posted by Michael Wonder on 18 Jun 2021
Let's have permanently quicker drug approvals
16 June 2021 - New drugs and vaccines likely to increase life expectancy, quality of life and save money, so we ...
Posted by Michael Wonder on 17 Jun 2021
Shared decision making underpins good health care
17 June 2021 - Shared decision making between service users and health care professionals is an integral part of health care, ...
Posted by Michael Wonder on 25 May 2021
ICER publishes protocol for first annual assessment of drug coverage policies that present barriers to fair access
25 May 2021 - ICER’s analysis, based on MMIT’s market access analytics solution, will evaluate how 15 of the largest ...
Posted by Michael Wonder on 18 May 2021
Quebec announces intention to implement a biosimilar switching policy
18 May 2021 - Biosimilars Canada today congratulated the Government of Quebec and Minister of Health and Social Services Christian ...
Posted by Michael Wonder on 18 May 2021
Sandoz Canada congratulates the Quebec government on implementing a shift towards biosimilars
18 May 2021 - The shift announced by Quebec will follow a similar approach to policies introduced in British Columbia, Alberta ...
Posted by Michael Wonder on 26 Apr 2021
ICER publishes white paper evaluating policy options to strengthen FDA’s accelerated approval pathway for prescription drugs
26 April 2021 - Informed by expert input from patient groups, former regulators, payers, and life science companies, white paper analyses ...
Posted by Michael Wonder on 22 Apr 2021
New Brunswick becomes third province in Canada to implement biosimilar switching policy
21 April 2021 - Biosimilars Canada today congratulated the Government of New Brunswick for implementing a biosimilar "switching" or transitioning ...
Posted by Michael Wonder on 20 Apr 2021
NICE’s five year strategy sets a ‘positive vision for the future’
20 April 2021 - The pharma industry has responded to the NICE new five year strategy, announced yesterday. ...
Posted by Michael Wonder on 14 Apr 2021
PhRMA's three part approach to build a better health care system
13 April 2021 - Our plan is based on three key pillars: ending the pandemic and building a more resilient system, ...
Posted by Michael Wonder on 13 Apr 2021
National cabinet to return to 'war footing' in effort to fix problem-plagued COVID vaccine rollout
13 April 2021 - Prime Minister Scott Morrison has asked the National Cabinet to hold two meetings a week to try ...
Posted by Michael Wonder on 21 Jan 2021
Who goes first? Government leaders and prioritisation of SARS-CoV-2 vaccine
20 January 2021 - The vice president, Senate majority leader, House speaker, surgeon general, and members of Congress were among the ...